JP2021527077A5 - - Google Patents
Info
- Publication number
- JP2021527077A5 JP2021527077A5 JP2020568685A JP2020568685A JP2021527077A5 JP 2021527077 A5 JP2021527077 A5 JP 2021527077A5 JP 2020568685 A JP2020568685 A JP 2020568685A JP 2020568685 A JP2020568685 A JP 2020568685A JP 2021527077 A5 JP2021527077 A5 JP 2021527077A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- composition according
- subunit
- seq
- nanoparticle
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684229P | 2018-06-13 | 2018-06-13 | |
| US62/684,229 | 2018-06-13 | ||
| PCT/US2019/036917 WO2019241483A1 (en) | 2018-06-13 | 2019-06-13 | Nanoparticle vaccines with novel structural components |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527077A JP2021527077A (ja) | 2021-10-11 |
| JPWO2019241483A5 JPWO2019241483A5 (https=) | 2022-06-20 |
| JP2021527077A5 true JP2021527077A5 (https=) | 2022-06-20 |
| JP7555826B2 JP7555826B2 (ja) | 2024-09-25 |
Family
ID=68843607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568685A Active JP7555826B2 (ja) | 2018-06-13 | 2019-06-13 | 新規構造成分を含有するナノ粒子ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11097002B2 (https=) |
| EP (1) | EP3807210A4 (https=) |
| JP (1) | JP7555826B2 (https=) |
| KR (1) | KR20210021530A (https=) |
| CN (1) | CN112469661B (https=) |
| AU (1) | AU2019285048B2 (https=) |
| CA (1) | CA3103460A1 (https=) |
| EA (1) | EA202092808A1 (https=) |
| IL (1) | IL279351B2 (https=) |
| SG (1) | SG11202012313PA (https=) |
| WO (1) | WO2019241483A1 (https=) |
| ZA (1) | ZA202100032B (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7730640B2 (ja) * | 2017-11-01 | 2025-08-28 | ザ スクリプス リサーチ インスティテュート | 新規足場ｈｉｖ－１ワクチン免疫原 |
| AU2020323462A1 (en) * | 2019-07-26 | 2022-03-10 | The Scripps Research Institute | Engineered HCV E2 immunogens and related vaccine compositions |
| MX2022009836A (es) * | 2020-02-11 | 2022-11-30 | Us Health | Vacuna para sars-cov-2. |
| BR112022016197A2 (pt) * | 2020-02-14 | 2022-10-25 | Univ Washington | Polipeptídeos e seus usos |
| CN113121704B (zh) * | 2020-03-25 | 2023-04-07 | 昆山新蕴达生物科技有限公司 | 基于纳米颗粒的冠状病毒疫苗 |
| US11559577B2 (en) | 2020-03-31 | 2023-01-24 | Engimata, Inc. | Immunogenic composition forming a vaccine, and a method for its manufacture |
| US11278617B2 (en) | 2020-03-31 | 2022-03-22 | Engimata, Inc | Immunogenic composition forming a SARS-CoV-2 vaccine, and a method for its manufacture |
| CN112023035A (zh) * | 2020-04-07 | 2020-12-04 | 中国医学科学院医学生物学研究所 | 一种以SARS-CoV-2病毒S蛋白RBD区为抗原的纳米疫苗及其制备 |
| US12194157B2 (en) | 2020-04-09 | 2025-01-14 | Finncure Oy | Carrier for targeted delivery to a host |
| FI20205382A1 (en) * | 2020-04-09 | 2021-05-07 | Niemelae Erik | Method for preventing the spreading and lowering the infection rate of pathogens |
| EP4132478A1 (en) | 2020-04-09 | 2023-02-15 | Finncure Oy | Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses |
| TW202204397A (zh) | 2020-04-10 | 2022-02-01 | 美商亞得捷歐治療公司 | 對冠狀病毒s蛋白質具特異性之化合物及其用途 |
| US20230149535A1 (en) * | 2020-04-11 | 2023-05-18 | The Wistar Institute Of Anatomy & Biology | Vaccines for coronavirus and methods of using the same |
| WO2021210984A1 (en) * | 2020-04-17 | 2021-10-21 | Erasmus University Medical Center Rotterdam | Coronavirus vaccine |
| KR20220153767A (ko) * | 2021-05-12 | 2022-11-21 | (주)인테라 | 엔캡슐린 기반 뎅기 바이러스 또는 코로나 바이러스 백신 생산을 위한 재조합 발현 벡터 및 이의 제조방법 |
| WO2021249116A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
| WO2021249011A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Hiv vaccine compositions, methods, and uses thereof |
| US20210403509A1 (en) * | 2020-06-24 | 2021-12-30 | Avalon GloboCare Corp. | S-layer vaccine fusion proteins and methods of use |
| US10906944B2 (en) * | 2020-06-29 | 2021-02-02 | The Scripps Research Institute | Stabilized coronavirus spike (S) protein immunogens and related vaccines |
| CA3190148A1 (en) * | 2020-08-10 | 2022-02-17 | The Scripps Research Institute | Compositions and methods related to ebolavirus vaccines |
| WO2022041760A1 (en) | 2020-08-31 | 2022-03-03 | Sichuan Clover Biopharmaceuticals, Inc. | Methods and compositions for purification of trimeric fusion proteins |
| IL302645A (en) * | 2020-11-03 | 2023-07-01 | The Wistrar Inst Of Anatomy And Biology | Dna encoded nanoparticles and method of use thereof as a coronavirus disease 2019 (covid-19) vaccine |
| CN114230674B (zh) * | 2020-12-01 | 2023-09-26 | 中国医学科学院基础医学研究所 | 一种含Fc结构域的新型冠状病毒S蛋白受体结合域融合蛋白及其用途 |
| EP4262864A4 (en) * | 2020-12-18 | 2025-06-04 | The Scripps Research Institute | IMMUNOGENIC COMPOSITIONS |
| US20240226272A9 (en) * | 2020-12-18 | 2024-07-11 | The Scripps Research Institute | Immunogenic compositions |
| WO2022173940A1 (en) * | 2021-02-10 | 2022-08-18 | Duke University | Coronavirus spike protein designs, compositions and methods for their use |
| CN112979826B (zh) * | 2021-03-03 | 2022-04-08 | 华中农业大学 | 一种乙型脑炎病毒纳米颗粒疫苗及其制备方法和应用 |
| US20230181717A1 (en) * | 2021-12-14 | 2023-06-15 | The Scripps Research Institute | Methods and compositions related to hiv-1 nanoparticle vaccines with improved properties |
| WO2024006532A2 (en) * | 2022-06-30 | 2024-01-04 | La Jolla Institute For Immunology | Kari nanoparticle |
| WO2024050452A2 (en) * | 2022-08-30 | 2024-03-07 | Administrators Of The Tulane Educational Fund | Compositions and methods for raising immune responses to gram-negative bacteria |
| CN115894716B (zh) * | 2022-11-23 | 2024-02-09 | 华中农业大学 | 一种重组融合蛋白纳米颗粒及其制备方法 |
| WO2024123558A2 (en) * | 2022-12-05 | 2024-06-13 | The Scripps Research Institute | Engineered lassa viral immunogens and vaccine compositions |
| AU2024280139A1 (en) | 2023-05-30 | 2026-01-22 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine composition, method therefor and use thereof |
| AU2024287014A1 (en) | 2023-06-07 | 2026-01-22 | Sichuan Clover Biopharmaceuticals, Inc. | Rsv vaccine composition, method and use thereof |
| CN121758569A (zh) * | 2023-11-03 | 2026-03-31 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒p15蛋白的免疫原性组合物及其应用 |
| CN121758570A (zh) * | 2023-11-03 | 2026-03-31 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒CD2v蛋白的免疫原性组合物及其应用 |
| CN120923628A (zh) * | 2024-05-09 | 2025-11-11 | 菲鹏生物股份有限公司 | 融合抗原及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU698962B2 (en) | 1993-09-14 | 1998-11-12 | Epimmune, Inc. | Alteration of immune response using pan DR-binding peptides |
| US7550143B2 (en) | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| AU2006232310B9 (en) * | 2005-04-06 | 2011-07-21 | Ibc Pharmaceuticals, Inc. | Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| WO2008063331A2 (en) | 2006-10-23 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof |
| RU2540871C2 (ru) | 2008-02-01 | 2015-02-10 | Альфа-О Пептидес Аг | Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин |
| EP2391635B1 (en) * | 2009-01-28 | 2017-04-26 | Epimmune Inc. | Pan-dr binding polypeptides and uses thereof |
| IN2012DN01331A (https=) * | 2009-08-31 | 2015-06-05 | Ibc Pharmaceuticals Inc | |
| CN104136454A (zh) * | 2011-10-12 | 2014-11-05 | 阿尔法-O肽股份公司 | 作为针对诺如病毒感染的疫苗的自装配肽纳米粒 |
| EP2765138B1 (en) | 2012-11-05 | 2018-01-10 | International Aids Vaccine Initiative | HIV-1 envelope glycoprotein |
| AP2015008634A0 (en) | 2013-01-07 | 2015-07-31 | Beth Israel Hospital | Stabilized human immunodeficiency virus 'hiv' env elope 'env' trimer vaccines and methods of using same |
| CN105247118A (zh) * | 2013-03-14 | 2016-01-13 | 多伦多大学管理委员会 | 支架化肽文库以及其制备和筛选方法 |
| CA2934472A1 (en) * | 2014-01-09 | 2015-07-16 | Alpha-O Peptides Ag | Flagellin-containing protein nanoparticles as a vaccine platform |
| WO2016037154A1 (en) | 2014-09-04 | 2016-03-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recombinant hiv-1 envelope proteins and their use |
| US10501733B2 (en) | 2015-02-27 | 2019-12-10 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
| SG11201809387QA (en) | 2016-05-02 | 2018-11-29 | Scripps Research Inst | Compositions and methods related to hiv-1 immunogens |
| AR109528A1 (es) | 2016-09-15 | 2018-12-19 | Janssen Vaccines & Prevention Bv | Mutaciones estabilizantes de trímeros de proteínas de la envoltura del vih |
| EA201991918A1 (ru) * | 2017-03-23 | 2020-05-15 | Альфа-О Пептидс Аг | Самосборные белковые наночастицы со встроенными белками с шестиспиральным пучком |
| WO2018187515A1 (en) * | 2017-04-04 | 2018-10-11 | Avidea Technologies, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
| JP7730640B2 (ja) | 2017-11-01 | 2025-08-28 | ザ スクリプス リサーチ インスティテュート | 新規足場ｈｉｖ－１ワクチン免疫原 |
| US10906944B2 (en) * | 2020-06-29 | 2021-02-02 | The Scripps Research Institute | Stabilized coronavirus spike (S) protein immunogens and related vaccines |
-
2019
- 2019-06-13 CN CN201980048606.3A patent/CN112469661B/zh active Active
- 2019-06-13 EA EA202092808A patent/EA202092808A1/ru unknown
- 2019-06-13 SG SG11202012313PA patent/SG11202012313PA/en unknown
- 2019-06-13 WO PCT/US2019/036917 patent/WO2019241483A1/en not_active Ceased
- 2019-06-13 US US16/440,067 patent/US11097002B2/en active Active
- 2019-06-13 AU AU2019285048A patent/AU2019285048B2/en active Active
- 2019-06-13 CA CA3103460A patent/CA3103460A1/en active Pending
- 2019-06-13 IL IL279351A patent/IL279351B2/en unknown
- 2019-06-13 EP EP19818872.4A patent/EP3807210A4/en active Pending
- 2019-06-13 JP JP2020568685A patent/JP7555826B2/ja active Active
- 2019-06-13 KR KR1020217001153A patent/KR20210021530A/ko active Pending
-
2021
- 2021-01-04 ZA ZA2021/00032A patent/ZA202100032B/en unknown
- 2021-07-27 US US17/386,289 patent/US12447206B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527077A5 (https=) | ||
| JPWO2019241483A5 (https=) | ||
| JP7555826B2 (ja) | 新規構造成分を含有するナノ粒子ワクチン | |
| AU2007239354B2 (en) | N protein fusion proteins of a virus in the Paramyxoviridae-protein of interest family | |
| AU2014230822B2 (en) | Heat-stable Respiratory Syncytial Virus prefusion F protein oligomers and their use in immunological compositions | |
| JP5751741B2 (ja) | 免疫原性組成物および使用法 | |
| US9801927B2 (en) | Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof | |
| JP2008529558A5 (https=) | ||
| JP2021502807A5 (https=) | ||
| JP2019522626A5 (https=) | ||
| CA2925201A1 (en) | Self-assembled nanoparticle vaccines | |
| AU2016289492A1 (en) | Vaccine against RSV | |
| JP2009544614A5 (https=) | ||
| IL274130B2 (en) | Novel scaffolded hiv-1 vaccine immunogens | |
| CN107849558A (zh) | 2型人副流感病毒载体和疫苗 | |
| US20210309973A1 (en) | Bacteriophage-Based Antibodies and Binders | |
| US20210401969A1 (en) | Rsv virus-like particles and methods of use thereof | |
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| CA2450548C (en) | Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments | |
| CN110234347A (zh) | 使用了非感染性副粘病毒粒子的传染病疫苗 | |
| US20230355737A1 (en) | Particle comprising an rsv-f protein for use in rsv vaccination | |
| JP2024545833A (ja) | コロナウイルス科ウイルスによる感染症の処置または予防のためのウイルス様粒子 | |
| CN117177766A (zh) | 疫苗平台 | |
| JPWO2021046398A5 (https=) | ||
| US11826421B2 (en) | Bacteriophage-based vaccines and engineered bacteriophage |